Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics

Benu Brata Das, Nilkantha Sen, Somdeb Bose Dasgupta, Agneyo Ganguly, Rakhee Das, Hemanta K. Majumder

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

Protozoan parasites of the order Kinetoplastida cause severe diseases primarily in the tropical and subtropical areas. The enormous development of molecular and cellular biology in recent times have provided opportunities for discovering newer molecular targets for drug designing, which now form a rational basis for the development of improved anti-parasitic therapy. DNA topoisomerases play a key role in cellular processes affecting the topology and organization of intracellular DNA. Recently, emergence of the bi-subunit topoisomerase I in the kinetoplastid family has brought a new twist in topoisomerase research related to evolution, functional conservation and as a potential target that can be exploited in drug designing and development of new intervention strategies. This review summarizes the biology of kinetoplastid topoisomerases, which are the key molecular targets in antileishmanial chemotherapy.

Original languageEnglish (US)
Pages (from-to)221-232
Number of pages12
JournalIndian Journal of Medical Research
Volume123
Issue number3
StatePublished - Mar 1 2006

Fingerprint

Leishmania
Parasites
Kinetoplastida
DNA Topoisomerases
Cytology
Type I DNA Topoisomerase
Molecular biology
Chemotherapy
Research
Pharmaceutical Preparations
Cell Biology
Molecular Biology
Conservation
Topology
Drug Therapy
DNA
Therapeutics

Keywords

  • DNA topoisomerase
  • Kinetoplastids
  • Leishmania
  • Therapeutic targets

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Das, B. B., Sen, N., Dasgupta, S. B., Ganguly, A., Das, R., & Majumder, H. K. (2006). Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics. Indian Journal of Medical Research, 123(3), 221-232.

Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics. / Das, Benu Brata; Sen, Nilkantha; Dasgupta, Somdeb Bose; Ganguly, Agneyo; Das, Rakhee; Majumder, Hemanta K.

In: Indian Journal of Medical Research, Vol. 123, No. 3, 01.03.2006, p. 221-232.

Research output: Contribution to journalReview article

Das, BB, Sen, N, Dasgupta, SB, Ganguly, A, Das, R & Majumder, HK 2006, 'Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics', Indian Journal of Medical Research, vol. 123, no. 3, pp. 221-232.
Das, Benu Brata ; Sen, Nilkantha ; Dasgupta, Somdeb Bose ; Ganguly, Agneyo ; Das, Rakhee ; Majumder, Hemanta K. / Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics. In: Indian Journal of Medical Research. 2006 ; Vol. 123, No. 3. pp. 221-232.
@article{27ec40a0036c466dbc41b6e8ec27e7b4,
title = "Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics",
abstract = "Protozoan parasites of the order Kinetoplastida cause severe diseases primarily in the tropical and subtropical areas. The enormous development of molecular and cellular biology in recent times have provided opportunities for discovering newer molecular targets for drug designing, which now form a rational basis for the development of improved anti-parasitic therapy. DNA topoisomerases play a key role in cellular processes affecting the topology and organization of intracellular DNA. Recently, emergence of the bi-subunit topoisomerase I in the kinetoplastid family has brought a new twist in topoisomerase research related to evolution, functional conservation and as a potential target that can be exploited in drug designing and development of new intervention strategies. This review summarizes the biology of kinetoplastid topoisomerases, which are the key molecular targets in antileishmanial chemotherapy.",
keywords = "DNA topoisomerase, Kinetoplastids, Leishmania, Therapeutic targets",
author = "Das, {Benu Brata} and Nilkantha Sen and Dasgupta, {Somdeb Bose} and Agneyo Ganguly and Rakhee Das and Majumder, {Hemanta K.}",
year = "2006",
month = "3",
day = "1",
language = "English (US)",
volume = "123",
pages = "221--232",
journal = "Indian Journal of Medical Research",
issn = "0971-5916",
publisher = "Indian Council of Medical Research",
number = "3",

}

TY - JOUR

T1 - Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics

AU - Das, Benu Brata

AU - Sen, Nilkantha

AU - Dasgupta, Somdeb Bose

AU - Ganguly, Agneyo

AU - Das, Rakhee

AU - Majumder, Hemanta K.

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Protozoan parasites of the order Kinetoplastida cause severe diseases primarily in the tropical and subtropical areas. The enormous development of molecular and cellular biology in recent times have provided opportunities for discovering newer molecular targets for drug designing, which now form a rational basis for the development of improved anti-parasitic therapy. DNA topoisomerases play a key role in cellular processes affecting the topology and organization of intracellular DNA. Recently, emergence of the bi-subunit topoisomerase I in the kinetoplastid family has brought a new twist in topoisomerase research related to evolution, functional conservation and as a potential target that can be exploited in drug designing and development of new intervention strategies. This review summarizes the biology of kinetoplastid topoisomerases, which are the key molecular targets in antileishmanial chemotherapy.

AB - Protozoan parasites of the order Kinetoplastida cause severe diseases primarily in the tropical and subtropical areas. The enormous development of molecular and cellular biology in recent times have provided opportunities for discovering newer molecular targets for drug designing, which now form a rational basis for the development of improved anti-parasitic therapy. DNA topoisomerases play a key role in cellular processes affecting the topology and organization of intracellular DNA. Recently, emergence of the bi-subunit topoisomerase I in the kinetoplastid family has brought a new twist in topoisomerase research related to evolution, functional conservation and as a potential target that can be exploited in drug designing and development of new intervention strategies. This review summarizes the biology of kinetoplastid topoisomerases, which are the key molecular targets in antileishmanial chemotherapy.

KW - DNA topoisomerase

KW - Kinetoplastids

KW - Leishmania

KW - Therapeutic targets

UR - http://www.scopus.com/inward/record.url?scp=33745216445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745216445&partnerID=8YFLogxK

M3 - Review article

VL - 123

SP - 221

EP - 232

JO - Indian Journal of Medical Research

JF - Indian Journal of Medical Research

SN - 0971-5916

IS - 3

ER -